Discussion on: Artificial Intelligence in the Optimisation of Glucagon-Like Peptide-1 Receptor agonist Therapy for Obesity and Type 2 Diabetes: A Critical Narrative Review of Treatment Monitoring and Clinical Decision Support

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title
Artificial Intelligence in the Optimisation of Glucagon-Like Peptide-1 Receptor agonist Therapy for Obesity and Type 2 Diabetes: A Critical Narrative Review of Treatment Monitoring and Clinical Decision Support
Authored by

Mirembe Katabaazi Lillian
Department of Pharmacovigilance, Feyti Medical Group Kampala, Uganda.

Anyebe Daniel Ameh
College of Professional Studies, University of Denver. Denver, Colorado, USA.

Jacob Miracle Godswill
Rivers State University of Science and technology, Port Harcourt, Rivers State, Nigeria.

Nana Ama Aduma Amankwah
Department of Health and Wellness Services, Western Illinois University, Macomb Illinois, USA.

DOI or Article Link

https://doi.org/10.56557/jomahr/2026/v11i210991

Leave a Comment